Innate Pharma S.A. (OTCMKTS:IPHYF – Get Free Report) saw a large growth in short interest during the month of June. As of June 15th, there was short interest totalling 7,900 shares, a growth of 43.6% from the May 31st total of 5,500 shares. Based on an average trading volume of 1,100 shares, the short-interest ratio is currently 7.2 days.
Innate Pharma Price Performance
IPHYF remained flat at $2.49 during trading on Monday. The stock’s fifty day simple moving average is $2.39 and its two-hundred day simple moving average is $2.60. Innate Pharma has a fifty-two week low of $2.13 and a fifty-two week high of $3.36.
About Innate Pharma
Further Reading
- Five stocks we like better than Innate Pharma
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Investing in Travel Stocks Benefits
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- 3 Warren Buffett Stocks to Buy Now
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Innate Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innate Pharma and related companies with MarketBeat.com's FREE daily email newsletter.